NFKB1 and brain neoplasm: To test the direct involvement of STAT3 pathway activation in the NF-κB pathway downstream of CHI3L1 action, we used WP1066, a selective inhibitor of STAT3 phosphorylation currently used in clinical trials for pediatric and adult brain tumors (48).